Applied DNA Sciences (NASDAQ:APDN) Posts Earnings Results

Applied DNA Sciences (NASDAQ:APDN) issued its earnings results on Thursday. The technology company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.24), Zacks reports. Applied DNA Sciences had a negative net margin of 203.76% and a negative return on equity of 111.18%.

Applied DNA Sciences Stock Performance

Applied DNA Sciences stock traded down $0.02 during trading hours on Thursday, hitting $0.17. 4,032,253 shares of the stock were exchanged, compared to its average volume of 3,094,619. Applied DNA Sciences has a 12 month low of $0.12 and a 12 month high of $14.40. The business’s 50-day moving average is $0.19 and its two-hundred day moving average is $0.52. The stock has a market capitalization of $9.61 million, a P/E ratio of -0.03 and a beta of 0.37.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.